SHBG expression has been linked to PI3K/AKT pathway function in a human cellular model of insulin resistance [65] and to inhibition of hepatic lipogenesis in mouse models by reducing PPARγ activation [48]. The gene discussed is PPARG; the disease is Insulin resistance.